(1) Background: This study aimed to investigate the association between radioactive iodine
(RAI) and long-term cardiovascular disease (CVD) morbidity/mortality in thyroid cancer.(2) …

Background Radioactive iodine (RAI) treatment is a standard treatment in differentiated
thyroid cancer (TC). However, its adverse effects on cardiovascular diseases (CVDs) have …

Purpose The risk of cardiovascular diseases' death (CVD) in patients with differentiated
thyroid cancer (DTC) treated with radioactive iodine (RAI) after surgery has not been …

Objective: To determine the association between thyroid cancer and coronary artery
disease, atrial fibrillation, cerebrovascular disease, and cardiovascular disease mortality …

Abstract Treatment with levothyroxine and radioiodine contribute alternative cardiovascular
function in adults with thyroid cancer. The risks of long-term cardiovascular conditions …

Background The purpose of this study was to evaluate the association between radioiodine
(I‐131) therapy for thyroid cancer and the risk of stroke in Taiwan. Methods A total of 10 104 …

Background: Despite the excellent disease-specific survival associated with low-risk
differentiated thyroid cancer (DTC), its diagnosis and management have been linked to …

Background: Radioactive iodine (RAI) is widely used for the treatment of thyroid cancers.
However, information on associations between RAI dose and second primary malignancy …

Simple Summary The cardiovascular effects of radioiodine (131I) therapy on people with
differentiated thyroid cancer (DTC) and concomitant type 2 diabetes mellitus (T2DM) are …

Radioactive iodine (RAI) is a key component in the treatment of differentiated thyroid cancer.
RAI has been recommended more selectively in recent years as guidelines evolve to reflect …